You are here: Home » PTI Stories » National » News
Business Standard

Companies say hydroxychloroquine in short supply

Topics
Health Medical Pharma

AP  |  Fairless Hills (US) 

Six drugmakers that manufacture generic hydroxychloroquine report the drug is in short supply, while three others reported in the last week that their product is available, according to the Food and Drug Administration's drug shortages website.

The companies cite increased demand as the cause, with some stating they expect to next ship the drug at the end of May.

President Donald Trump said Monday he has been taking hydroxychloroquine and a zinc supplement daily for about a week and a half now, after two White House staffers tested positive for the coronavirus.

Trump has spent months pushing hydroxychloroquine as a potential cure or preventive drug for COVID-19 against the cautionary advice of many of his administration's top medical professionals.

One of the companies, Concordia Pharmaceuticals, also makes the brand-name version, called Paquenil. It says that drug is completely unavailable but is expected to be available again at the end of this month.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, May 19 2020. 23:18 IST
RECOMMENDED FOR YOU